LATS1 and hepatocellular carcinoma: Immunoblot revealed that XMU-MP-1 treatment reversed the α-hederin-induced expression changes of Mst1, Lats1, P-Lats1/2, YAP, P-YAP, TAZ in HCC cells (Figure 5A).